Allweiss L. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. PS-162.
Chronische hepatitis B: wie kan stoppen met nucleos(t)ideanalogen?
jun 2022 | Hepatitis, Hepatologie, Virale infecties